• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

认知表现最佳者对阿尔茨海默病病理的抵抗力

Resilience to AD pathology in Top Cognitive Performers.

作者信息

Dominguez Elena Nicole, Corrada María M, Kawas Claudia H, Stark Craig E L

机构信息

Department of Neurobiology and Behavior, University of California, Irvine, Irvine, CA, United States.

Department of Neurology, University of California, Irvine, Irvine, CA, United States.

出版信息

Front Aging Neurosci. 2024 Jul 11;16:1428695. doi: 10.3389/fnagi.2024.1428695. eCollection 2024.

DOI:10.3389/fnagi.2024.1428695
PMID:39055052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11270559/
Abstract

Successful cognitive aging is often thought to result from resistance to the accumulation of pathology, resilience to the effects of pathological accumulation, or some combination of the two. While evidence for resilience has been found in typical aging populations, the oldest-old provide us with a unique window into the role of pathological accumulation in impacting cognition. Here, we aimed to assess group differences in measures of amyloid and tau across older age groups using data from the Alzheimer's Disease Neuroimaging Initiative (ADNI age: 60-89) and + (age: 90-101). Additionally, using the ADNI dataset, we performed exploratory analyses of regional cingulate AV-45 SUVRs to assess if amyloid load in particular areas was associated with Top Cognitive Performance (TCP). Consistent with the literature, results showed no group differences in amyloid SUVRs both regionally and in the whole cortex. For tau with AV-1451, we also observed no differences in Braak composite SUVRs. Interestingly, these relationships persisted in the oldest-old. This indicates that Top Cognitive Performance throughout aging does not reflect resistance to amyloid and tau burden, but that other mechanisms may be associated with protection against amyloid and tau related neurodegeneration.

摘要

成功的认知衰老通常被认为源于对病理积累的抵抗、对病理积累影响的恢复力,或两者的某种组合。虽然在典型的老年人群中已发现恢复力的证据,但最年长的老年人为我们提供了一个独特的窗口,以了解病理积累在影响认知方面的作用。在这里,我们旨在利用来自阿尔茨海默病神经影像倡议(ADNI,年龄60 - 89岁)和ADNI+(年龄90 - 101岁)的数据,评估不同老年组在淀粉样蛋白和tau蛋白测量指标上的组间差异。此外,使用ADNI数据集,我们对扣带回区域的AV - 45标准化摄取值(SUVRs)进行了探索性分析,以评估特定区域的淀粉样蛋白负荷是否与顶级认知表现(TCP)相关。与文献一致,结果显示区域和整个皮质的淀粉样蛋白SUVRs均无组间差异。对于使用AV - 1451检测的tau蛋白,我们在Braak综合SUVRs中也未观察到差异。有趣的是,这些关系在最年长的老年人中依然存在。这表明在整个衰老过程中,顶级认知表现并不反映对淀粉样蛋白和tau蛋白负担的抵抗,而是其他机制可能与预防淀粉样蛋白和tau蛋白相关的神经退行性变有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/11270559/4017e332a7ea/fnagi-16-1428695-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/11270559/58486132e715/fnagi-16-1428695-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/11270559/ac626a11c1d2/fnagi-16-1428695-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/11270559/4017e332a7ea/fnagi-16-1428695-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/11270559/58486132e715/fnagi-16-1428695-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/11270559/ac626a11c1d2/fnagi-16-1428695-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/11270559/4017e332a7ea/fnagi-16-1428695-g0003.jpg

相似文献

1
Resilience to AD pathology in Top Cognitive Performers.认知表现最佳者对阿尔茨海默病病理的抵抗力
Front Aging Neurosci. 2024 Jul 11;16:1428695. doi: 10.3389/fnagi.2024.1428695. eCollection 2024.
2
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
3
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
4
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
5
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
6
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.胆碱酯酶抑制剂治疗血管性痴呆和其他血管性认知障碍:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Feb 22;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2.
7
Pharmacotherapies for sleep disturbances in dementia.痴呆症睡眠障碍的药物治疗
Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3.
8
Inhaled mannitol for cystic fibrosis.吸入用甘露醇治疗囊性纤维化。
Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3.
9
A Novel Design of a Portable Birdcage via Meander Line Antenna (MLA) to Lower Beta Amyloid (Aβ) in Alzheimer's Disease.一种通过曲折线天线(MLA)设计的便携式鸟笼,用于降低阿尔茨海默病中的β淀粉样蛋白(Aβ)。
IEEE J Transl Eng Health Med. 2025 Apr 10;13:158-173. doi: 10.1109/JTEHM.2025.3559693. eCollection 2025.
10
Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease.皮质 Tau 正电子发射断层扫描模式在临床前阿尔茨海默病患者中的差异。
JAMA Neurol. 2022 Jun 1;79(6):592-603. doi: 10.1001/jamaneurol.2022.0676.

引用本文的文献

1
Age-dependent interactions of APOE isoform 4 and Alzheimer's disease neuropathology: findings from the NACC.载脂蛋白E异构体4与阿尔茨海默病神经病理学的年龄依赖性相互作用:来自国家阿尔茨海默病协调中心(NACC)的研究结果
Acta Neuropathol Commun. 2025 May 17;13(1):102. doi: 10.1186/s40478-025-02012-0.

本文引用的文献

1
Successful cognitive aging is associated with thicker anterior cingulate cortex and lower tau deposition compared to typical aging.与典型衰老相比,成功的认知老化与前扣带皮层增厚和 tau 沉积减少有关。
Alzheimers Dement. 2024 Jan;20(1):341-355. doi: 10.1002/alz.13438. Epub 2023 Aug 24.
2
Brain structure and phenotypic profile of superagers compared with age-matched older adults: a longitudinal analysis from the Vallecas Project.超级老年人与年龄匹配的老年人的大脑结构和表型特征比较:来自 Vallecas 项目的纵向分析。
Lancet Healthy Longev. 2023 Aug;4(8):e374-e385. doi: 10.1016/S2666-7568(23)00079-X. Epub 2023 Jul 13.
3
Superior Global Cognition in Oldest-Old Is Associated with Resistance to Neurodegenerative Pathologies: Results from The 90+ Study.
高龄老人认知能力超群与抵抗神经退行性病变有关:来自 90+ 研究的结果。
J Alzheimers Dis. 2023;93(2):561-575. doi: 10.3233/JAD-221062.
4
A framework for concepts of reserve and resilience in aging.衰老储备和恢复力的概念框架。
Neurobiol Aging. 2023 Apr;124:100-103. doi: 10.1016/j.neurobiolaging.2022.10.015. Epub 2022 Dec 19.
5
Alzheimer's polygenic hazard score in SuperAgers: SuperGenes or SuperResilience?超级长寿者的阿尔茨海默病多基因风险评分:超级基因还是超级恢复力?
Alzheimers Dement (N Y). 2022 Aug 2;8(1):e12321. doi: 10.1002/trc2.12321. eCollection 2022.
6
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.阿尔茨海默病临床谱系中淀粉样蛋白异常的患病率估计
JAMA Neurol. 2022 Mar 1;79(3):228-243. doi: 10.1001/jamaneurol.2021.5216.
7
Kidney Function Is Not Related to Brain Amyloid Burden on PET Imaging in The 90+ Study Cohort.在90岁及以上研究队列中,肾脏功能与PET成像上的脑淀粉样蛋白负荷无关。
Front Med (Lausanne). 2021 Sep 20;8:671945. doi: 10.3389/fmed.2021.671945. eCollection 2021.
8
Assessment of Tau Tangles and Amyloid-β Plaques Among Super Agers Using PET Imaging.使用正电子发射断层扫描评估超级老年人的 Tau 缠结和淀粉样-β斑块。
JAMA Netw Open. 2020 Dec 1;3(12):e2028337. doi: 10.1001/jamanetworkopen.2020.28337.
9
White matter hypointensities and hyperintensities have equivalent correlations with age and CSF β-amyloid in the nondemented elderly.在非痴呆的老年人中,脑白质低信号和高信号与年龄和 CSF β-淀粉样蛋白具有同等相关性。
Brain Behav. 2019 Dec;9(12):e01457. doi: 10.1002/brb3.1457. Epub 2019 Nov 6.
10
White Matter Hyperintensities and Hippocampal Atrophy in Relation to Cognition: The 90+ Study.脑白质高信号与海马萎缩与认知的关系:90+研究。
J Am Geriatr Soc. 2019 Sep;67(9):1827-1834. doi: 10.1111/jgs.15990. Epub 2019 Jun 6.